Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems
Open Access
- 1 January 2017
- journal article
- review article
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-9
Abstract
New generation vaccines, based on isolated antigens, are safer than traditional ones, comprising the whole pathogen. However, major part of purified antigens has weak immunogenicity. Therefore, elaboration of new adjuvants, more effective and safe, is an urgent problem of vaccinology. Tubular immunostimulating complexes (TI-complexes) are a new type of nanoparticulate antigen delivery systems with adjuvant activity. TI-complexes consist of cholesterol and compounds isolated from marine hydrobionts: cucumarioside A2-2 (CDA) fromCucumaria japonicaand monogalactosyldiacylglycerol (MGDG) from marine algae or seagrass. These components were selected due to immunomodulatory and other biological activities. Glycolipid MGDG from marine macrophytes comprises a high level of polyunsaturated fatty acids (PUFAs), which demonstrate immunomodulatory properties. CDA is a well-characterized individual compound capable of forming stable complex with cholesterol. Such complexes do not possess hemolytic activity. Ultralow doses of cucumariosides stimulate cell as well as humoral immunity. Therefore, TI-complexes comprising biologically active components turned out to be more effective than the strongest adjuvants: immunostimulating complexes (ISCOMs) and complete Freund’s adjuvant. In the present review, we discuss results published in series of our articles on elaboration, qualitative and quantitative composition, ultrastructure, and immunostimulating activity of TI-complexes. The review allows immersion in the history of creating TI-complexes.Keywords
Funding Information
- Russian Science Foundation (15-15-00035)
This publication has 46 references indexed in Scilit:
- Ulososides and Urabosides — Triterpenoid Saponins from the Caribbean Marine Sponge Ectyoplasia feroxMolecules, 2013
- Tubular immunostimulating complex based on cucumarioside A2-2 and monogalactosyldiacylglycerol from marine macrophytesJournal of Nanobiotechnology, 2011
- Polyunsaturated fatty acids and inflammatory processes: New twists in an old taleBiochimie, 2009
- Review of the Apoptosis Pathways in Pancreatic Cancer and the Anti‐apoptotic Effects of the Novel Sea Cucumber Compound, Frondoside AAnnals of the New York Academy of Sciences, 2008
- Telomerase inhibition by sulfoquinovosyldiacylglycerol from edible purple laver (Porphyra yezoensis)Cancer Letters, 2004
- Monoglucosyldiacylglycerol, a Foreign Lipid, Can Substitute for Phosphatidylethanolamine in Essential Membrane-associated Functions in Escherichia coliJournal of Biological Chemistry, 2004
- Sulfoquinovosyldiacylglycerol, KM043, a New Potent Inhibitor of Eukaryotic DNA Polymerases and HIV-Reverse Transcriptase Type 1 from a Marine Red Alga, Gigartina tenella.Chemical and Pharmaceutical Bulletin, 1998
- Anti-tumour-promoting glyceroglycolipids from the green alga, Chlorella vulgarisPhytochemistry, 1995
- Liposomes and ISCOMS as vaccine formulationsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- AIDS-Antiviral Sulfolipids From Cyanobacteria (Blue-Green Algae)JNCI: Journal of the National Cancer Institute, 1989